Cartesian Therapeutics, Inc.
RNACAs of the close on Sep 25, 2026
Price
$7.41
Market cap
$224M
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Cartesian Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Cartesian Therapeutics, Inc. — 10-K filed Mar 9, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 6, 2026. The latest institutional report shown is dated Jun 30, 2024; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| MetLife Investment Management, LLC | 2024-06-30 | 410 | Not shown | SEC filing |
| CWM, LLC | 2024-06-30 | 4 | Not shown | SEC filing |
| OSAIC HOLDINGS, INC. | 2024-06-30 | 62 | Not shown | SEC filing |
| Royal Bank of Canada | 2024-03-31 | 66,554 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2024-03-31 | 1,425,154 | Not shown | SEC filing |
| Legal & General Group Plc | 2024-03-31 | 11,634 | Not shown | SEC filing |
| MORGAN STANLEY | 2024-03-31 | 220,942 | Not shown | SEC filing |
| Voya Investment Management LLC | 2024-03-31 | 45,996 | Not shown | SEC filing |
| MORGAN STANLEY | 2024-03-31 | 220,942 | Not shown | SEC filing |
| Legal & General Group Plc | 2024-03-31 | 11,634 | Not shown | SEC filing |
| BARCLAYS PLC | 2024-03-31 | 118,953 | Not shown | SEC filing |
| DEUTSCHE BANK AG\ | 2024-03-31 | 65,815 | Not shown | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2024-03-31 | 45,131 | Not shown | SEC filing |
| Erste Asset Management GmbH | 2024-03-31 | 3,212,093 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2023-12-31 | 1,480,810 | Not shown | SEC filing |
| Erste Asset Management GmbH | 2023-12-31 | 3,127,000 | Not shown | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2023-12-31 | 45,131 | Not shown | SEC filing |
| Voya Investment Management LLC | 2023-12-31 | 49,796 | Not shown | SEC filing |
| Legal & General Group Plc | 2023-12-31 | 11,634 | Not shown | SEC filing |
| BARCLAYS PLC | 2023-12-31 | 200,171 | Not shown | SEC filing |
- Each value is checked against Cartesian Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Erste Asset Management GmbH: 3,127,000 shares reported 2023-12-31; 3,212,093 shares reported 2024-03-31.
- NEW YORK STATE COMMON RETIREMENT FUND: 45,131 shares reported 2023-12-31; 45,131 shares reported 2024-03-31.
- BARCLAYS PLC: 200,171 shares reported 2023-12-31; 118,953 shares reported 2024-03-31.
- Voya Investment Management LLC: 49,796 shares reported 2023-12-31; 45,996 shares reported 2024-03-31.
- JPMORGAN CHASE & CO: 1,480,810 shares reported 2023-12-31; 1,425,154 shares reported 2024-03-31.
- Erste Asset Management GmbH: 2,527,000 shares reported 2023-09-30; 3,127,000 shares reported 2023-12-31.
- NEW YORK STATE COMMON RETIREMENT FUND: 45,266 shares reported 2023-09-30; 45,131 shares reported 2023-12-31.
- BARCLAYS PLC: 59,665 shares reported 2023-09-30; 200,171 shares reported 2023-12-31.
- Voya Investment Management LLC: 49,796 shares reported 2023-09-30; 49,796 shares reported 2023-12-31.
- Erste Asset Management GmbH: 2,327,000 shares reported 2023-06-30; 2,527,000 shares reported 2023-09-30.
- NEW YORK STATE COMMON RETIREMENT FUND: 84,800 shares reported 2023-06-30; 45,266 shares reported 2023-09-30.
- BARCLAYS PLC: 61,240 shares reported 2023-06-30; 59,665 shares reported 2023-09-30.
Showing the 12 most recent filer reports.
5 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Cartesian Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-03-20 · SPRINGER TIMOTHY A: Larger than 47 of the 51 other insider purchases of Common Stock on file. SEC filing
- 2024-11-21 · Kurtoglu Metin: Larger than 27 of the 28 other insider sales of Common Stock on file. SEC filing
- 2024-11-15 · SPRINGER TIMOTHY A: Larger than 49 of the 51 other insider purchases of Common Stock on file. SEC filing
- 2024-11-15 · Kurtoglu Metin: Larger than 26 of the 28 other insider sales of Common Stock on file. SEC filing
- 2024-11-14 · SPRINGER TIMOTHY A: Larger than 48 of the 51 other insider purchases of Common Stock on file. SEC filing
- 2024-11-14 · Miljkovic Milos: Larger than all 28 other insider sales of Common Stock on file. SEC filing
- 2024-10-03 · SPRINGER TIMOTHY A: Larger than 46 of the 51 other insider purchases of Common Stock on file. SEC filing
- 2024-03-15 · SPRINGER TIMOTHY A: Larger than 50 of the 51 other insider purchases of Common Stock on file. SEC filing
- 2024-03-14 · SPRINGER TIMOTHY A: Larger than all 51 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-06 | Davis Blaine · Chief Financial Officer | Common Stock | S — Open market or private sale | −10,591 | 6.82 | SEC filing |
| 2026-01-06 | Brunn Carsten · President and CEO | Common Stock | S — Open market or private sale | −23,766 | 6.82 | SEC filing |
| 2026-01-06 | Miljkovic Milos · Chief Medical Officer | Common Stock | S — Open market or private sale | −3,573 | 6.82 | SEC filing |
| 2025-12-04 | BARABE TIMOTHY C · Director | Common Stock | P — Open market or private purchase | +30,000 | 6.86 | SEC filing |
| 2025-04-11 | SPRINGER TIMOTHY A · Director, 10% owner | Common Stock | P — Open market or private purchase | +6,412 | 10.77 | SEC filing |
| 2025-04-11 | SPRINGER TIMOTHY A · Director, 10% owner | Common Stock | P — Open market or private purchase | +36,338 | 10.77 | SEC filing |
| 2025-04-10 | SPRINGER TIMOTHY A · Director, 10% owner | Common Stock | P — Open market or private purchase | +7,966 | 10.43 | SEC filing |
| 2025-04-10 | SPRINGER TIMOTHY A · Director, 10% owner | Common Stock | P — Open market or private purchase | +609 | 10.92 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-02 | Kalayoglu Murat · 10% owner | Common Stock | M — Exercise or conversion of derivative security | +758,001 | SEC filing |
| 2026-04-02 | Seven One Eight Three Four Irrevocable Trust · 10% owner | Series A Non-Voting Convertible Preferred Stock | M — Exercise or conversion of derivative security | −22,740 | SEC filing |
| 2026-04-02 | Seven One Eight Three Four Irrevocable Trust · 10% owner | Common Stock | M — Exercise or conversion of derivative security | +758,001 | SEC filing |
| 2026-04-02 | Kalayoglu Murat · 10% owner | Series A Non-Voting Convertible Preferred Stock | M — Exercise or conversion of derivative security | −22,740 | SEC filing |
| 2026-03-13 | Singer Michael · Director | Common Stock | G — Bona fide gift | −6,555 | SEC filing |
| 2026-01-02 | ZENNER PATRICK J · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +7,800 | SEC filing |
| 2026-01-02 | Kalayoglu Murat · Director, 10% owner | Common Stock | A — Grant, award, or other acquisition | +2,600 | SEC filing |
| 2026-01-02 | ZENNER PATRICK J · Director | Common Stock | A — Grant, award, or other acquisition | +2,600 | SEC filing |
Showing 8 of 25 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-10-02 | SPRINGER TIMOTHY A · Director, 10% owner | Warrant (Right to Buy) | J — Other acquisition or disposition | −133,632 | SEC filing |
| 2024-10-02 | SPRINGER TIMOTHY A · Director, 10% owner | Warrant (Right to Buy) | J — Other acquisition or disposition | +20,045 | SEC filing |
| 2024-10-02 | SPRINGER TIMOTHY A · Director, 10% owner | Common Stock | J — Other acquisition or disposition | −2,119,193 | SEC filing |
| 2024-10-02 | SPRINGER TIMOTHY A · Director, 10% owner | Common Stock | J — Other acquisition or disposition | +1,801,314 | SEC filing |
| 2024-10-02 | SPRINGER TIMOTHY A · Director, 10% owner | Common Stock | J — Other acquisition or disposition | +317,879 | SEC filing |
| 2024-10-02 | SPRINGER TIMOTHY A · Director, 10% owner | Warrant (Right to Buy) | J — Other acquisition or disposition | +113,587 | SEC filing |
Showing 6 of 6 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.